Effects of anti-tal-1 oligodeoxynucleotides in T-ALL cell lines

Cancer Gene Therapy

Volumn 4, Issue 2, 1997, Pages 84-90

  Anderegg, Birgit ^a   Horstmann, Martin ^a   Kabisch, Hartmut ^a  

^a UNIVERSITY OF HAMBURG   (Germany)

Author keywords

Antisense oligodeoxynucleotides; Fusion genes; SIL; T ALL; tal 1; Transcription factors

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; DNA BINDING PROTEIN; HYBRID PROTEIN; MESSENGER RNA; ONCOPROTEIN; PROTEIN; SIL PROTEIN, HUMAN; TAL1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

ARTICLE; BIOSYNTHESIS; CELL CULTURE; CELL DIVISION; DOSE RESPONSE; DRUG EFFECT; GENETICS; HUMAN; MUTATION; PATHOLOGY; T CELL LEUKEMIA;

BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL DIVISION; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LEUKEMIA, T-CELL, ACUTE; MUTATION; OLIGONUCLEOTIDES, ANTISENSE; ONCOGENE PROTEINS, FUSION; PROTEINS; PROTO-ONCOGENE PROTEINS; RECOMBINANT FUSION PROTEINS; RNA, MESSENGER; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 0031089448     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Begley CG, Aplan PD, Davey MP, et al. Chromosomal translocation in a human leukemic stem-cell line disrupts the T-cell antigen receptor δ-chain diversity region and results in a previously unreported fusion transcript. Proc Natl Acad Sci USA. 1989;86:2031-2035.
2. Finger LR, Kagan J, Christopher G, et al. Involvement of the TCL5 gene on human chromosome 1 in T-cell leukemia and melanoma. Proc Natl Acad Sci USA. 1989;86: 5039-5043.
3. Borkhardt A, Repp R, Harbott J, et al. Frequency and DNA sequence of tal-1 rearrangement in children with T-cell acute lymphoblastic leukemia. Ann Hematol. 1992; 64:305-308.
4. Brown L, Cheng J-T, Chen Q, et al. Site-specific recombination of the tal-1 gene is a common occurrence in human T cell leukemia. EMBO J. 1990;9:3343-3351.
5. Aplan PD, Lombardi DP, Ginsberg AM, et al. Disruption of the human SCL locus by "illegitimate" V-(D)-J recombinase activity. Science. 1990;250:1426-1429.
6. Bernard O, Lecointe N, Jonveaux P, et al. Two site-specific deletions and t(1;14) translocation restricted to human T-cell acute leukemias disrupt the 5′ part of the tal-1 gene. Oncogene. 1991;6:1477-1488.
7. Aplan PD, Lombardi DP, Kirsch IR. Structural characterization of SIL, a gene frequently disrupted in T-cell acute lymphoblastic leukemia. Mol Cell Biol. 1991;11:5462-5469.
8. Aplan PD, Lombardi DP, Reaman GH, et al. Involvement of the putative hematopoietic transcription factor SCL in T-cell acute lymphoblastic leukemia. Blood. 1992;79:1327-1333.
9. Fitzgerald TJ, Neale GAM, Raimondi SC, Goorha RM. c-tal, a helix-loop-helix protein, is juxtaposed to the T-cell receptor-β chain gene by a reciprocal chromosomal translocation: t(1;7)(p32;q35). Blood. 1991;78:2686-2695.
10. Aplan PD, Johnson BE, Russell E, et al. Cloning and characterization of TCTA, a gene located at the site of a t(1;3) translocation. Cancer Res. 1995;55:1917-1921.
11. Visvader J, Begley CG, Adams JM. Differential expression of the LYL, SCL and E2A helix-loop-helix genes within the hemopoietic system. Oncogene. 1991;6:187-194.
12. Aplan PD, Nakahara K, Orkin SH, Kirsch IR. The SCL gene product: a positive regulator of erythroid differentiation. EMBO J. 1992;11:4073-4081.
13. Green AR, Lints T, Visvader J, et al. SCL is coexpressed with GATA-1 in hematopoietic cells but is also expressed in developing brain. Oncogene. 1992;7:653-660.
14. Hwang L-Y, Siegelman M, Davis L, et al. Expression of the TALI proto-oncogene in cultured endothelial cells and blood vessels of the spleen. Oncogene. 1993;8:3043-3046.
15. Kallianpur AR, Jordan JE, Brandt SJ. The SCL/TAL-1 gene is expressed in progenitors of both the hematopoietic and vascular systems during embryogenesis. Blood. 1994; 83:1200-1208.
16. Anderegg B, Horstmann M, Ernst M, Kabisch H. Transcription of tal-1, a putative oncogene playing an important role in childhood T-ALL, can be shown in normal peripheral blood cells by a highly sensitive RT-PCR assay. Ped Hematol Oncol. In press.
17. Begley CG, Aplan PD, Denning SM, et al. The gene SCL is expressed during early hematopoiesis and encodes a differentiation-related DNA-binding motif. Proc Natl Acad Sci USA. 1989;86:10128-10132.
18. Chen Q, Cheng J-T, Tsai L-H, et al. The tal gene undergoes chromosome translocation in T cell leukemia and potentially encodes a helix-loop-helix protein. EMBO J. 1990;9:415-424.
19. Aplan PD, Begley CG, Bertness V, et al. The SCL gene is formed from a transcriptionally complex locus. Mol Cell Biol 1990;10:6426-6435.
20. Murre C, McCaw PS, Baltimore D. A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins. Cell. 1989;56: 777-783.
21. Hsu H-L, Cheng J-T, Chen Q, Baer R. Enhancer binding activity of the tal-1 oncoprotein in association with the E47/E12 helix-loop-helix proteins. Mol Cell Biol. 1991;11: 3037-3042.
22. Murre C, McCaw PS, Vaessin H, et al. Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence. Cell. 1989;58:537-544.
23. Green AR, DeLuca E, Begley CG. Antisense SCL suppresses self-renewal and enhances spontaneous erythroid differentiation of the human leukaemic cell line K562. EMBO J. 1991;10:4153-4158.
24. Vaerman JL, Lammineur C, Moureau P, et al. BCR-ABL antisense oligodeoxyribonucleotides suppress the growth of leukemic and normal hematopoietic cells by a sequence-specific but nonantisense mechanism. Blood. 1995;86:3891-3896.
25. Nakajima-Iijima S, Hamada H, Reddy P, Takanuga TS. Molecular structure of the human cytoplasmic β-actin gene: Intraspecies homology of sequences in the introns. Proc Natl Acad Sci USA. 1985;82:6133-6137.
26. Southern E. Detection of specific DNA sequences among DNA fragments separated by gel electrophoresis. J Mol Biol. 1975;98:503-517.
27. Breit TM, Mol EJ, Wolvers-Tettero ILM, et al. Site-specific deletions involving the tal-1 and sil genes are restricted to cells of the T-cell receptor αβ lineage: T-cell receptor δ gene deletion mechanism affects multiple genes. J Exp Med. 1993;177:965-977.
28. Jonsson OG, Kitchens RL, Baer RJ, et al. Rearrangements of the tal-1 locus as clonal markers for T cell acute lymphoblastic leukemia. J Clin Invest. 1991;87:2029-2035.
29. Mouthon M-A, Bernard O, Mitjavila M-T, et al. Expression of tal-1 and GATA-binding proteins during human hematopoiesis. Blood. 1993;81:647-655.
30. Cross MA, Heyworth CM, Murrell AM, et al. Expression of lineage restricted transcription factors precedes lineage specific differentiation in a multipotent haemopoietic progenitor cell line. Oncogene. 1994;9:3013-3016.